Disclaimer: The drug’s indications and dose calculation are based on the FDA-approved package insert. The treatment regime shown in this tool are referenced in a peer-reviewed journal. There may be new regimens or new indications approved later by the FDA. This later information may not be included in this tool. This tool has no intention to promote any of Roche’s products. The price of Atezolizumab and Bevacizumab are the average price available at government hospitals in Thailand. It does not include the price of biosimilars (if any) because biosimilars may exhibit different safety profiles in terms of the nature, seriousness or incidence of adverse reactions.